Akebia Therapeutics, Inc.
AKBA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001517022
No open-market purchases or sales by Akebia Therapeutics, Inc. insiders were filed in the last 90 days; 170 institutions reported holding it in 13F filings for Q2 2026, worth $123.2M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Akebia Therapeutics, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 65 | 79 | +14 |
| Shares | 52.0M | 50.3M | −1.70M (−3.3%) |
| Value | $29.1M | $46.0M | +$17.0M (+58.4%) |
New holders (22)
Institutions that held Akebia Therapeutics, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Qube Research & Technologies Ltd | 436,269 | $399.2K | 0.00% |
| XTX Topco Ltd | 339,367 | $310.5K | 0.06% |
| Two Sigma Investments, LP | 216,213 | $197.8K | 0.00% |
| State of Wyoming | 48,207 | $44.1K | 0.01% |
| Prudential Financial Inc | 47,509 | $43.5K | 0.00% |
| Invesco Ltd. | 31,992 | $29.3K | 0.00% |
| Advisory Services Network, LLC | 27,000 | $24.7K | 0.00% |
| Graham Capital Management, L.P. | 26,586 | $24.3K | 0.00% |
| Wolverine Trading, LLC | 20,198 | $18.7K | 0.00% |
| Mercer Global Advisors Inc | 19,960 | $18.0K | 0.00% |
| GTS Securities LLC | 17,549 | $16.1K | 0.00% |
| Sykon Capital LLC | 15,000 | $13.7K | 0.01% |
| Visionary Wealth Advisors | 14,819 | $13.6K | 0.00% |
| Envestnet Asset Management Inc | 14,000 | $12.8K | 0.00% |
| Ameritas Advisory Services, LLC | 12,096 | $12.3K | 0.00% |
| Raymond James & Associates | 11,602 | $10.6K | 0.00% |
| RB Capital Management, LLC | 10,000 | $9.15K | 0.00% |
| First Horizon Advisors, Inc. | 5,600 | $5.12K | 0.00% |
| Rhumbline Advisers | 4,926 | $4.51K | 0.00% |
| PrairieView Partners, LLC | 4,000 | $3.00K | 0.00% |
| Citadel Advisors LLC | 965 | $883 | 0.00% |
| Royal Bank of Canada | 500 | $0 | 0.00% |
Sold out (8)
Institutions that held Akebia Therapeutics, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| HRT Financial LP | 148,681 | $83.0K |
| Icon Wealth Partners, LLC | 50,000 | $28.0K |
| LPL Financial LLC | 28,596 | $16.0K |
| Sunbelt Securities, Inc. | 14,000 | $7.88K |
| National Asset Management, Inc. | 13,000 | $7.29K |
| Assenagon Asset Management S.A. | 12,450 | $6.98K |
| Belpointe Asset Management LLC | 2,243 | $1.26K |
| Mirabella Financial Services LLP | 140,604 | – |